Ping Wang

发表

Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

Jiang F Zhong, Jiong Hu, P. Kong, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia

Zhi Yang, C. Qian, Chengcheng Zhang, 2019, Clinical Cancer Research.

Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature

Zhi Yang, P. Kong, X. Peng, 2018, Journal of immunotherapy.

Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR‐T containing either CD28 or 4‐1BB

Yanmin Xu, Junjie Shen, Zhi Yang, 2018, British journal of haematology.

Plasmacytoid Dendritic Cell Infiltration in Acute Myeloid Leukemia

Jiang F Zhong, P. Kong, X. Peng, 2020, Cancer management and research.

Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

Lei Gao, Yao Liu, Li Gao, 2020, Frontiers in Medicine.

Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation.

C. Zhang, P. Kong, Xing-hua Chen, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia

X. Peng, Li Gao, Ping Wang, 2018, Medicine.

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?

P. Kong, X. Peng, Lei Gao, 2020, Frontiers in Oncology.

Pretransplantation minimal residual disease monitoring by multiparameter flow cytometry predicts outcomes of AML patients receiving allogeneic hematopoietic stem cell transplantation.

X. Peng, Yi Li, Ping Wang, 2022, Transplant immunology.

Successful Treatment of Refractory and Relapsed CNS Acute Lymphoblastic Leukemia With CD-19 CAR-T Immunotherapy: A Case Report

Q. Gong, Ping Wang, Jieping Chen, 2021, Frontiers in Oncology.

Clonal evolution analyses of a chronic myeloid leukemia patient with hematopoietic stem cell transplantation based on deep sequencing

Q. Gong, Wei-Dong Li, Ping Wang, 2023, Holistic Integrative Oncology.

TKIs combined with chemotherapy followed by allo-HSCT in Philadelphia chromosome-positive myelodysplastic syndrome: A case report and literature review

Wenxiu Yang, Jishi Wang, Ping Wang, 2022, Medicine.

Tumor-forming plasmacytoid dendritic cells in acute myelocytic leukemia: a report of three cases and literature review.

X. Peng, Ping Wang, Xi Zhang, 2017, International journal of clinical and experimental pathology.

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia

Lei Gao, Ting Chen, Ping Wang, 2023, Frontiers in immunology.

Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes

Q. Gong, Shuangnian Xu, Xi Li, 2023, Annals of Hematology.

Cutaneous adverse drug reactions in Southwest China: Retrospective analysis of 448 cases of inpatients in a dermatology ward from 2010 to 2017

Zhiqiang Song, Ping Wang, Y. You, 2019, The Australasian journal of dermatology.